• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女护士中化妆品的使用及不良化妆品事件:建立化妆品警戒系统的必要性。

Use of Cosmetics and Adverse Cosmetic Events Among Female Nurses: Need for a Cosmetovigilance System.

作者信息

Khan Zakir, Karataş Yusuf, Pekkan Gönül, Çakır Güngör Ayşe Nur, Rahman Hazir, Khan Faiz Ullah, Kıroğlu Olcay

机构信息

Çukurova University Faculty of Medicine, Department of Medical Pharmacology, Adana, Türkiye.

Riphah International University Faculty of Pharmaceutical Sciences, Gulberg Green Campus, Islamabad, Pakistan.

出版信息

Turk J Pharm Sci. 2024 Sep 2;21(4):284-296. doi: 10.4274/tjps.galenos.2023.01379.

DOI:10.4274/tjps.galenos.2023.01379
PMID:39224061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11589096/
Abstract

OBJECTIVES

Cosmetics are known to cause adverse events in users, and there is limited information on this topic both globally and in Türkiye. This study was conducted to assess the use of cosmetics, patterns, and characteristics of adverse cosmetic events (ACEs) among female nurses.

MATERIALS AND METHODS

This cross-sectional study was conducted from February to April 2022 among registered female nurses with at least 1 year of work experience in a tertiary care hospital in Adana, Türkiye. A validated questionnaire was used for data collection, which included 13 questions with three main sections. The first part comprised demographic variables and cosmetic uses, the second part addressed ACE, and the final section consisted of consultation types and reporting methods for adverse events adopted after experiencing ACE.

RESULTS

Of the total 158 participants, 144 were included in this study, resulting in a response rate of 91.1%. All female nurses reported using cosmetics, and 26.4% (n= 38) reported experiencing one or more cosmetic ACEs. Itching, burning, and eczema were the most frequently observed ACEs. A higher proportion of ACEs were associated with face care products (18.4%) and deodorants (13.1%). More than half (57.9%) of the nurses did not consult with healthcare professionals after experiencing ACE. Moreover, most participants (47.4%) did not report ACE to healthcare authorities.

CONCLUSION

A considerable proportion of the participants reported ACEs. The underreporting of ACE was also highlighted in this study. The results also emphasize the need for a robust cosmetovigilance system.

摘要

目的

已知化妆品会在使用者身上引发不良事件,全球范围内以及土耳其关于这一主题的信息都很有限。本研究旨在评估女性护士使用化妆品的情况、不良化妆品事件(ACEs)的模式及特征。

材料与方法

本横断面研究于2022年2月至4月在土耳其阿达纳一家三级护理医院中对至少有1年工作经验的注册女护士开展。采用一份经过验证的问卷进行数据收集,问卷包含13个问题,分为三个主要部分。第一部分包括人口统计学变量和化妆品使用情况,第二部分涉及ACEs,最后一部分包括经历ACEs后所采用的不良事件咨询类型和报告方法。

结果

在总共158名参与者中,144名被纳入本研究,应答率为91.1%。所有女护士均报告使用化妆品,26.4%(n = 38)报告经历过一种或多种化妆品ACEs。瘙痒、灼烧感和湿疹是最常观察到的ACEs。较高比例的ACEs与面部护理产品(18.4%)和除臭剂(13.1%)有关。超过一半(57.9%)的护士在经历ACEs后未咨询医疗保健专业人员。此外,大多数参与者(47.4%)未向医疗保健当局报告ACEs。

结论

相当比例的参与者报告了ACEs。本研究还突出了ACEs报告不足的情况。研究结果还强调了建立健全化妆品警戒系统的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/11589096/c5e0d8d48a6a/TurkJPharmSci-21-284-figure-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/11589096/5c1f6d2b6f7c/TurkJPharmSci-21-284-figure-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/11589096/824df60a278c/TurkJPharmSci-21-284-figure-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/11589096/c5e0d8d48a6a/TurkJPharmSci-21-284-figure-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/11589096/5c1f6d2b6f7c/TurkJPharmSci-21-284-figure-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/11589096/824df60a278c/TurkJPharmSci-21-284-figure-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/11589096/c5e0d8d48a6a/TurkJPharmSci-21-284-figure-3.jpg

相似文献

1
Use of Cosmetics and Adverse Cosmetic Events Among Female Nurses: Need for a Cosmetovigilance System.女护士中化妆品的使用及不良化妆品事件:建立化妆品警戒系统的必要性。
Turk J Pharm Sci. 2024 Sep 2;21(4):284-296. doi: 10.4274/tjps.galenos.2023.01379.
2
Cosmetovigilance survey: are cosmetics considered safe by consumers?化妆品警戒调查:消费者认为化妆品安全吗?
Pharmacol Res. 2006 Jan;53(1):16-21. doi: 10.1016/j.phrs.2005.08.003. Epub 2005 Sep 23.
3
The Pattern of Use of Cosmetics and Awareness of Cosmetovigilance Among Medical Students in Puducherry: A Cross-Sectional Study.本地治里医学生的化妆品使用模式及化妆品警戒意识:一项横断面研究
Cureus. 2025 Feb 1;17(2):e78335. doi: 10.7759/cureus.78335. eCollection 2025 Feb.
4
Safety in Cosmetics and Cosmetovigilance, Current Regulations in Türkiye.土耳其化妆品安全与化妆品警戒,现行法规
Turk J Pharm Sci. 2022 Oct 31;19(5):610-617. doi: 10.4274/tjps.galenos.2021.40697.
5
Cosmetics Use-Related Adverse Events and Determinants Among Jigjiga Town Residents, Eastern Ethiopia.埃塞俄比亚东部吉吉加镇居民中与化妆品使用相关的不良事件及决定因素
Dermatol Ther (Heidelb). 2017 Mar;7(1):143-153. doi: 10.1007/s13555-016-0157-y. Epub 2016 Nov 23.
6
An observational study on adverse reactions of cosmetics: The need of practice the Cosmetovigilance system.一项关于化妆品不良反应的观察性研究:实施化妆品警戒系统的必要性
Saudi Pharm J. 2020 Jun;28(6):746-753. doi: 10.1016/j.jsps.2020.04.017. Epub 2020 May 11.
7
Cosmetovigilance in a tertiary care hospital: A prospective observational study.三级护理医院中的美容医疗监测:一项前瞻性观察研究。
J Cosmet Dermatol. 2021 Mar;20(3):804-811. doi: 10.1111/jocd.13646. Epub 2020 Aug 17.
8
Questionnaire-Based Study of 392 Women in Abbottabad, Pakistan, to Evaluate the Types of Cosmetic Products Purchased Between December 2018 and March 2019 and Their Associated Adverse Events.基于问卷的巴基斯坦阿伯塔巴德 392 名女性研究,评估 2018 年 12 月至 2019 年 3 月购买的化妆品类型及其相关不良事件。
Med Sci Monit Basic Res. 2024 Mar 29;30:e943048. doi: 10.12659/MSMBR.943048.
9
A cosmetovigilance survey in Europe.欧洲的一项化妆品警戒调查。
Pharmacol Res. 2007 May;55(5):455-60. doi: 10.1016/j.phrs.2007.01.022. Epub 2007 Feb 17.
10
A Cross-sectional Survey-based Study of Knowledge, Attitude, and Practice Towards Uses of Cosmetics and Cosmetovigilance in India.一项基于横断面调查的关于印度化妆品使用及化妆品警戒的知识、态度和实践的研究。
J Pharm Bioallied Sci. 2024 Jan-Mar;16(1):31-37. doi: 10.4103/jpbs.jpbs_413_23. Epub 2024 Mar 21.